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Elevated serum immunoglobulin-G4 (IgG4) has been
linked to several overlapping syndromes that are related to
IgG4-producing plasma cells. These clinical syndromes include
cholangitis, autoimmune hepatitis and pancreatitis, Sjögren’s syn-
drome, nephritis, and retroperitoneal fibrosis, and the spectrum of
this disease has been labeled “IgG4-related systemic disease.”
Management of IgG4-related systemic disease generally includes
immunosuppressive therapy; dramatic responses to medical ther-
apy have obviated surgical management in many cases.
Inflammatory aneurysms have long proved to be challenging
for vascular surgeons, with chronic periaortitis, inflammation, and
fibrosis increasing the difficulty of surgical repair, and, possibly
paradoxically, reducing the risk of rupture. The authors have
previously published their examination of a small series (n 10) of
inflammatory aneurysms, and showed that four of the 10 inflam-
matory aneurysms had abundant IgG4-positive plasma cells and
histological changes typical of IgG4-related systemic disease. In
this paper, the authors expand their examination to the 23 cases of
inflammatory aneurysms that were treated over 12 years, 13 cases
of which contained IgG4-positive plasma cells. These patients were
associated with reduced risk of rupture, other allergic or autoim-
mune disorders, and positive serology for IgG4, IgE, and anti-
nuclear antibody (ANA), compared with the 10 cases that did not
contain IgG4-positive plasma cells.
The implications of this report suggest that IgG4-related
inflammatory aneurysms may be treated medically, rather than
surgically; conversely, the high rate of rupture in IgG4-negativeranted. Optimal medical and surveillance strategies need to be
defined for IgG4-related aneurysms, and optimal surgical strate-
gies, that minimize complication risk, need to be defined for
IgG4-negative aneurysms. As the only other report of IgG4-
related inflammatory aneurysm disease has come from another
Japanese group,1 the utility of these observations will be clari-
fied as they are extended to other populations.
There are implications for other vascular diseases as well. For
example, Kawasaki disease is an acute inflammatory childhood
vasculitis with intense secretion of cytokines that permanently
damage the vascular endothelium and typically result in coronary
aneurysms. This disease is usually treated with immune globulin
and aspirin, with steroid therapy being controversial. Should Ka-
wasaki disease prove to be IgG4-related, then additional insights
into its management will be obtained.
Ultimately, the increasing importance of the role of the im-
mune system in the pathogenesis of atherosclerosis is being recog-
nized. If IgG4-related systemic disease plays a causative role in the
formation of atherosclerosis in even a small subset of patients,
medical therapy for this important vascular disease may ultimately
prove to be a reality.
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